<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-165325</identifier>
<setSpec>1695-3703</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Treatment with rich platelets autologous plasma in a sterile patient with suspected refractory endometrium</dc:title>
<dc:description xml:lang="en">36 years old patient with primary sterility of 2 years. An oocyte donation was decided after the study. An endometrial thickness slimmed was observed in different visits. With the diagnosis of refractory endometrium, a treatment was performed with high-dose estrogen, vitamin E and pentoxifylline for 3 months. As the endometrial thickness did not increase, we associated AAS. Finally intrauterine platelet-rich autologous plasma was administered. At 96 hours 7.3 mm of endometrium was observed, two vitrified embryos transferred, resulting in a biochemical abortion. Discussion: The medical treatment of refractory endometrium is a challenge. There are many therapies, hormonal and nonhormonal options. However, most of these options are poorly evaluated so they require better designed studies and larger sample size (AU)</dc:description>
<dc:creator>Roldrán Gutiérrez, L</dc:creator>
<dc:creator>Pérez Matos, C</dc:creator>
<dc:creator>Santana Suárez, MA</dc:creator>
<dc:creator>Álvarez Sánchez, M</dc:creator>
<dc:creator>Torres Alfonso, A</dc:creator>
<dc:creator>Machado Rider, Y</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Paciente de 36 años con esterilidad primaria de 2 años. Tras estudio completo se decide donación de ovocitos. En los controles se observa un grosor endometrial adelgazado. Con el diagnóstico de endometrio refractario, se realiza un tratamiento con estrógenos a altas dosis, vitamina E y pentoxifilina durante 3 meses. Como el grosor endometrial no aumenta, asociamos AAS. Finalmente se administra intraútero plasma autólogo rico en plaquetas. A las 96 horas se observa un endometrio de 7,3 mm, transfiriéndose dos embriones vitrificados, resultando en un aborto bioquímico. Discusión: El tratamiento médico del endometrio refractario constituye un reto. Existen numerosas opciones terapéuticas, hormonales y no hormonales. Sin embargo, la mayoría de estas opciones están escasamente evaluadas por lo que se requieren de estudios mejor diseñados y con mayor tamaño muestral (AU)</dc:description>
<dc:source>Rev. iberoam. fertil. reprod. hum;34(2): 23-27, abr.-jun. 2017. ilus</dc:source>
<dc:identifier>ibc-165325</dc:identifier>
<dc:title xml:lang="es">Tratamiento con plasma autólogo rico en plaquetas en una paciente estéril con un endometrio refractario</dc:title>
<dc:subject>^d331</dc:subject>
<dc:subject>^d36295^s22074</dc:subject>
<dc:subject>^d4796^s22032</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6326^s22012</dc:subject>
<dc:subject>^d52020</dc:subject>
<dc:subject>^d54249^s22074</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7424^s22067</dc:subject>
<dc:type>article</dc:type>
<dc:date>201706</dc:date>
</metadata>
</record>
</ibecs-document>
